Service agreement for pacific biosciences sequencer

This is a combined synopsis/solicitation for commercial items prepared in accordance with the

format in FAR 12.6 as supplemented with additional information included in this notice. This

announcement constitutes the only solicitation and a separate written solicitation will not be

issued. This solicitation number is NICHD-20-072 and is issued as a Request for Quotation

(RFQ). The solicitation/contract will include all applicable provisions and clauses in effect

through Federal Acquisition Circular 2020-05. The North American Industry Classification

(NAICS) Code is 811219 and the business size standard is $20.5M. However, this solicitation is

not set aside for small business. This acquisition is being conducted using Simplified

Acquisition Procedures in accordance with FAR Part 13. Eunice Kennedy Shriver National

Institute of Child Health and Human Development (NICHD) intends to contract on a sole source

basis with Pacific Biosciences – 1305 O’Brien Drive – Menlo, Park, CA 94025 to procure a

Comprehensive PacBio Sequel Service Agreement w/Insight for one calendar year (begin date

TBD) for the following:

PacBio DNA Sequel Instrument – SN: SQ54233 – Quantity (1) EA

The service agreement provides the following (Subject to Pacific Biosciences Standard Terms

and Conditions and applicable Service Contract Data Sheet) but not limited to:

Covering of all parts, labor and consumables required for the repair and recommended

preventative maintenance of an installed system with priority service. Monitor, diagnose and

control the Sequel remotely using proprietary Insight software.

The uniqueness and sophistication of the machine requires highly specialized care and

maintenance. This machine is critical to the operation of the lab/sequencing facility and there are

no other machines at NIH at that can be used as a back-up in case of downtime. Investigators

need to have their DNA samples sequenced using this machine to understand genetics, disease

and move precision medicine forward. Thus, continuous operation of the Sequel sequencing

machine is needed to provide single-molecule, long-read DNA sequence to NICHD

investigators. The specialized field engineers from Pacific Biosciences are essential for the

operation of this equipment. In addition, engineers at Pacific Biosciences headquarters can

monitor, diagnose and control the Sequel remotely using proprietary software (Insight).

The proposed contract action is for supplies or services for which the Government intends to

solicit and negotiate with only one source under authority of the 41 U.S.C. 253(c) (1), FAR

6.302. This notice of intent is not a request for competitive quotations.

The offeror must include a completed copy of the provision of FAR Clause 52.212-3, Offeror

Representations and Certifications – Commercial Items with its offer. The provisions of FAR

Clause 52.212-1 Instructions to Offerors – Commercial Items; FAR Clause 52.212-2, Evaluation

– Commercial Items factors: technical capability to provide all services and or parts as per

solicitation, price and past performance. Technical capability and past performance, when

combined, are more important than cost/price; FAR Clause 52.212-4, Contract Terms and

Conditions – Commercial Items; and FAR 52.212-5, Contract Terms and Conditions Required to

Implement Statutes or Executive Orders – Commercial Items – Deviation for Simplified

Acquisitions applies to this acquisition. The offeror must include their Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), and the certification of business size. Offers must include a signed agreement with Pacific Biosciences authorizing that you can provide the needed services for the DNA Sequencer, use original manufacture parts and maintain existing warranties, etc. The clauses are available in full text at http://www.acquisition.gov/far/. Interested vendors capable of furnishing the government with the service specified in this synopsis should submit a copy of their quotation to the below address or via email to

robinsti@mail.nih.gov. Responses to this solicitation must include enough information to establish the interested parties’ bona-fide capabilities of providing all products and service (s) needed. Responses must be accompanied by descriptive literature, warranties and/or other information that demonstrates that the offer meets all the foregoing requirements.

Quotations will be due w/in eleven calendar days from the publication date of this synopsis by (NLT) 9:00 am EST on March 30, 2020 via email or postal mail or other mailing services. The quotation must reference “Solicitation number” NICHD-20-072. All responsible sources may submit a quotation, which if timely received, shall be considered by the agency. Quotations sent by postal mail or other mailing services must be submitted to the following address: Eunice Kennedy Shriver National Institute of Child Health and Human Development, 6710B Rockledge Drive, MSC 1159B, Bethesda, MD 20892. Attention: Tina Robinson, by the date and time mentioned above. Any questions must be sent via email to robinsti@mail.nih.gov and must include solicitation# NICHD-20-072 in the subject line of email. Faxed copies/responses will not be accepted.

Note: In order to receive an award, contractor must have an active registration for all awards in the SAM database @www.sam.gov